EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

In Vitro Investigation of LIFU-Triggered, Visualizable Bionic Nanoparticles for a “Three-In-One” Therapy Against Medullary Thyroid Carcinoma

Xiangzhi Zhao, Weiwei Zhu, Zhengchao Fan, Junan Zhou, Ying Li, Zihan Zhao, Dingjie Shu, Song Su, Jizhu Xia iD

Technology in Cancer Research & Treatment · 2026

DOI: 10.1177/15330338261492797 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Technology in Cancer Research & Treatment, 2026. Verfasst von Xiangzhi Zhao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ultrasound, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China. Hauptthemen laut MEDLINE: Carcinoma, Neuroendocrine, Thyroid Neoplasms, Nanoparticles. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Doctoral Start-up Fund of Affiliated Hospital of Southwest Medical University, Luzhou Municipal Science and Technology Bureau Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Medullary thyroid carcinoma (MTC) is an aggressive neuroendocrine malignancy with limited diagnostic strategies and inherent resistance to conventional therapies. Novel multifunctional Nanotheranostics are urgently needed to improve MTC treatment outcomes. This study aimed to construct a low-intensity focused ultrasound (LIFU)-responsive biomimetic nanoparticle system integrating multiple therapeutic modalities and dual-modal imaging for in vitro combined treatment of MTC.

Methods

A tumor cell membrane-camouflaged lipid nanoparticle (MHGA@P-LNs) was fabricated to co-load hematoporphyrin monomethyl ether (HMME), glucose oxidase (GOx), AQ4N, and perfluorohexane (PFH). In vitro assays characterized physicochemical properties, LIFU responsiveness, cellular uptake, reactive oxygen species production, cytotoxicity, apoptosis, migration, and hemocompatibility. All experiments were repeated in triplicate (n = 3).

Results

MHGA@P-LNs exhibited a uniform core-shell morphology, favorable colloidal stability, and high drug encapsulation efficiency. Under LIFU irradiation, the system generated ultrasound/photoacoustic signals, increased intracellular ROS-associated fluorescence, and enhanced uptake by MZ-CRC-1 cells. Cell viability decreased to 0.9%, the total apoptosis rate reached 86.8%, and wound closure was 3.7%. The hemolysis rate remained below 3% in a mouse red blood cell assay. These results are limited to the in vitro experimental conditions.

Conclusion

The in vitro data support further investigation of MHGA@P-LNs as a LIFU-responsive, image-guided combination-therapy platform for medullary thyroid carcinoma. The present findings do not establish in vivo tumor accumulation, prolonged circulation, immune evasion, metastatic targeting, systemic safety, or clinical translatability; these outcomes require dedicated animal studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, NeuroendocrineThyroid NeoplasmsNanoparticlesHumansCell Line, TumorApoptosisReactive Oxygen SpeciesAnimalsUltrasonic TherapyMiceTheranostic Nanomedicine

Stichwörter der Autor:innen

Biomimetic nanoparticleHypoxia-activated prodrugLow-intensity focused ultrasoundMedullary thyroid carcinomaSonodynamic therapy

Substanzen

Reactive Oxygen Species

Autor:innen und Institutionen

  • Department of Ultrasound, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China.
  • Health Management Center, First Affiliated Hospital of Army Medical University (Southwest Hospital), Chongqing, China.
  • Department of Ultrasound, Sichuan First Hospital of Traditional Chinese Medicine, Chengdu, Sichuan, China.
  • Department of General Surgery (Hepatobiliary Surgery), The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China.
  • Department of Plastic and Burns Surgery, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China.

ORCID-Profile: Jizhu Xia

Förderung

  • Doctoral Start-up Fund of Affiliated Hospital of Southwest Medical University
  • Luzhou Municipal Science and Technology Bureau Project

Zitieren

APA

Zhao, X., Zhu, W., Fan, Z., Zhou, J., Li, Y., Zhao, Z., Shu, D., Su, S., & Xia, J. (2026). In Vitro Investigation of LIFU-Triggered, Visualizable Bionic Nanoparticles for a “Three-In-One” Therapy Against Medullary Thyroid Carcinoma. Technology in Cancer Research & Treatment. https://doi.org/10.1177/15330338261492797

Vancouver

Zhao X, Zhu W, Fan Z, Zhou J, Li Y, Zhao Z, et al. In Vitro Investigation of LIFU-Triggered, Visualizable Bionic Nanoparticles for a “Three-In-One” Therapy Against Medullary Thyroid Carcinoma. Technology in Cancer Research & Treatment. 2026. doi:10.1177/15330338261492797

BibTeX
@article{Zhao2026,
  author = {Zhao, Xiangzhi and Zhu, Weiwei and Fan, Zhengchao and Zhou, Junan and Li, Ying and Zhao, Zihan and Shu, Dingjie and Su, Song and Xia, Jizhu},
  title = {In Vitro Investigation of LIFU-Triggered, Visualizable Bionic Nanoparticles for a “Three-In-One” Therapy Against Medullary Thyroid Carcinoma},
  journal = {Technology in Cancer Research & Treatment},
  year = {2026},
  doi = {10.1177/15330338261492797}
}
Kostenlos starten →